Muthalik: BJP too appeasing Muslims; Will Modi speak against Iftar in Mutt?

Bengaluru, Feb 14: BJP leader and Karnataka Revenue Minister R Ashok refused to comment on the Bellary car accident case, allegedly involving his son, saying that the matter was still under investigation and that they did not have anything to do with the said car.

The car crash took place on February 10, when a speeding red Mercedes Benz allegedly driven by Ashok's son rammed into a tea stall by the roadside killing two people. While a 16-year-old boy Ravi died on the spot, one of the car's passengers was also killed in the accident.

"I came to know about the incident and also heard that two people have died and a few others have sustained injuries. Everybody is equal under the law. It is not fair to comment as a minister when the case is being investigated," Ashok told reporters here on Thursday.

However, the minister avoided answering questions about his son's presence in the car and said that they had "no connection" with the car.

"The case is in the investigation stage, I don't want to comment on anything. My son's name is not present in the FIR. We have no connection with the car," he said.

Superintendent of Police CK Baba told reporters that Ashok's son was not present in the car.

"There was no senior BJP leader and Revenue Ministers's son in the car. We will not hide anything and the case will be investigated," Baba said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Udupi, May 24: As many as 23 people tested positive for coronavirus in Udupi in past 24 hours, according to the latest bulletin released by the health and family welfare department.

While 18 were tested positive till noon, five more tested postive by evening.

With this the total number of covid-19 cases in the district rose to 76 including a death. Three have recovered. There 72 active cases.

Among 23 fresh cases, many had reportedly come from Maharashtra. A 44-year-old woman had returned from UAE. A 26-year-old man returned from Telangana.